The use of mouse models to better understand mechanisms of autoimmunity and tolerance

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 192-198

  Miyagawa, Fumi ^a   Gutermuth, Jan ^a   Zhang, Hong ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmunity; CD8 T cells; GvHD; Immunological tolerance; Transgenic mouse model

Indexed keywords

CYTOKERATIN 14; CYTOKINE; INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL SURFACE; DOSE RESPONSE; EPITHELIUM; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN; T LYMPHOCYTE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; KERATIN-14; MICE; MICE, TRANSGENIC; OVALBUMIN; PROMOTER REGIONS, GENETIC; RECEPTORS, ANTIGEN, T-CELL; SKIN;

EID: 77957810194     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.007     Document Type: Article

References (60)

1. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002, 2(1):11-19.
2. Lohr J., Knoechel B., Nagabhushanam V., Abbas A.K. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol Rev 2005, 204:116-127.
3. Abbas A.K., Lohr J., Knoechel B., Nagabhushanam V. T cell tolerance and autoimmunity. Autoimmun Rev 2004, 3(7-8):471-475.
4. Miller J.F., Flavell R.A. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr Opin Immunol 1994, 6(6):892-899.
5. Shibaki A., Sato A., Vogel J.C., Miyagawa F., Katz S.I. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol 2004, 123(1):109-115.
6. Kappler J.W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987, 49(2):273-280.
7. Kappler J.W., Staerz U., White J., Marrack P.C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 1988, 332(6159):35-40.
8. MacDonald H.R., Schneider R., Lees R.K., Howe R.C., Acha-Orbea H., Festenstein H., et al. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature 1988, 332(6159):40-45.
9. Kisielow P., Bluthmann H., Staerz U.D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988, 333(6175):742-746.
10. Morahan G., Allison J., Miller J.F. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 1989, 339(6226):622-624.
11. Miller J.F., Allison J., Morahan G., Cox K.O., Mulebacher A., Blanden R.V. Expression of class I histocompatibility antigens in defined tissues: effects on T cell function. Semin Immunol 1989, 1(2):137-146.
12. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991, 65(2):305-317.
13. Oldstone M.B., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991, 65(2):319-331.
14. Roman L.M., Simons L.F., Hammer R.E., Sambrook J.F., Gething M.J. The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 1990, 61(3):383-396.
15. Lo D., Freedman J., Hesse S., Palmiter R.D., Brinster R.L., Sherman L.A. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol 1992, 22(4):1013-1022.
16. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996, 184(3):923-930.
17. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997, 186(2):239-245.
18. Boyton R.J., Altmann D.M. Transgenic models of autoimmune disease. Clin Exp Immunol 2002, 127(1):4-11.
19. Morgan D.J., Kreuwel H.T., Sherman L.A. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 1999, 163(2):723-727.
20. Morgan D.J., Kurts C., Kreuwel H.T., Holst K.L., Heath W.R., Sherman L.A. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A 1999, 96(7):3854-3858.
21. Vezys V., Olson S., Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 2000, 12(5):505-514.
22. McGargill M.A., Derbinski J.M., Hogquist K.A. Receptor editing in developing T cells. Nat Immunol 2000, 1(4):336-341.
23. McGargill M.A., Mayerova D., Stefanski H.E., Koehn B., Parke E.A., Jameson S.C., et al. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J Immunol 2002, 169(4):2141-2147.
24. Mayerova D., Parke E.A., Bursch L.S., Odumade O.A., Hogquist K.A. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 2004, 21(3):391-400.
25. Azukizawa H., Kosaka H., Sano S., Heath W.R., Takahashi I., Gao X.H., et al. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003, 33(7):1879-1888.
26. Bursch L.S., Rich B.E., Hogquist K.A. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J Immunol 2009, 182(8):4657-4664.
27. Bianchi T., Pincus L.B., Wurbel M.A., Rich B.E., Kupper T.S., Fuhlbrigge R.C., et al. Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice. J Immunol 2009, 182(8):4665-4674.
28. Miyagawa F., Tagaya Y., Kim B.S., Patel H.J., Ishida K., Ohteki T., et al. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol 2008, 181(2):1109-1119.
29. Gutermuth J., Nograles K.E., Miyagawa F., Nelson E., Cho Y.H., Katz S.I. Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation. J Immunol 2009, 183(5):3130-3138.
30. Kim B.S., Miyagawa F., Cho Y.H., Bennett C.L., Clausen B.E., Katz S.I. Keratinocytes function as accessory cells for presentation of endogenous antigen expressed in the epidermis. J Invest Dermatol 2009, 129(12):2805-2817.
31. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997, 6(6):715-726.
32. Milner E., Barnea E., Beer I., Admon A. The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics 2006, 5(2):357-365.
33. Caron E., Charbonneau R., Huppe G., Brochu S., Perreault C. The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int Immunol 2005, 17(12):1583-1596.
34. Yewdell J.W., Nicchitta C.V. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol 2006, 27(8):368-373.
35. Weinzierl A.O., Lemmel C., Schoor O., Muller M., Kruger T., Wernet D., et al. Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics 2007, 6(1):102-113.
36. Li M., Davey G.M., Sutherland R.M., Kurts C., Lew A.M., Hirst C., et al. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001, 166(10):6099-6103.
37. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001, 19:47-64.
38. Ohashi P.S., DeFranco A.L. Making and breaking tolerance. Curr Opin Immunol 2002, 14(6):744-759.
39. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001, 194(6):769-779.
40. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002, 196(8):1091-1097.
41. Scheinecker C., McHugh R., Shevach E.M., Germain R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002, 196(8):1079-1090.
42. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002, 196(12):1627-1638.
43. Kurts C., Carbone F.R., Barnden M., Blanas E., Allison J., Heath W.R., et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997, 186(12):2057-2062.
44. Bansal-Pakala P., Jember A.G., Croft M. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 2001, 7(8):907-912.
45. Hernandez J., Aung S., Marquardt K., Sherman L.A. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med 2002, 196(3):323-333.
46. Kurts C., Sutherland R.M., Davey G., Li M., Lew A.M., Blanas E., et al. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A 1999, 96(22):12703-12707.
47. Rocha B., Grandien A., Freitas A.A. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med 1995, 181(3):993-1003.
48. Redmond W.L., Marincek B.C., Sherman L.A. Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo. J Immunol 2005, 174(4):2046-2053.
49. Redmond W.L., Sherman L.A. Peripheral tolerance of CD8 T lymphocytes. Immunity 2005, 22(3):275-284.
50. Curtsinger J.M., Lins D.C., Mescher M.F. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 2003, 197(9):1141-1151.
51. Curtsinger J.M., Valenzuela J.O., Agarwal P., Lins D., Mescher M.F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 2005, 174(8):4465-4469.
52. Azukizawa H., Sano S., Kosaka H., Sumikawa Y., Itami S. Prevention of toxic epidermal necrolysis by regulatory T cells. Eur J Immunol 2005, 35(6):1722-1730.
53. Liblau R., Tisch R., Bercovici N., McDevitt H.O. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol Today 1997, 18(12):599-604.
54. Aichele P., Brduscha-Riem K., Zinkernagel R.M., Hengartner H., Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med 1995, 182(1):261-266.
55. Aichele P., Kyburz D., Ohashi P.S., Odermatt B., Zinkernagel R.M., Hengartner H., et al. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci U S A 1994, 91(2):444-448.
56. Bercovici N., Heurtier A., Vizler C., Pardigon N., Cambouris C., Desreumaux P., et al. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage. J Immunol 2000, 165(1):202-210.
57. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
58. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
59. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
60. Gershwin M.E. The mosaic of autoimmunity. Autoimmun Rev 2008, 7:161-163.